| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/10/2008 | US7385034 Complementary DNAs encoding proteins with signal peptides |
| 06/10/2008 | US7385033 PRO12970 polypeptides |
| 06/10/2008 | US7385032 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 06/10/2008 | US7385031 PRO6097 polypeptides |
| 06/10/2008 | US7385030 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 06/10/2008 | US7385027 unlike calpastatin, the peptides of the invention do not target an active cysteine of calpain; protecting neurons against ultraviolet radiation induced cell death |
| 06/10/2008 | US7385026 Modified ghrelin polypeptides |
| 06/10/2008 | US7385024 For therapy of proliferative diseases (particularly cancer), acromegaly or diabetic nephropathies and retinopathies |
| 06/10/2008 | US7384918 Botulinum toxin for treating muscle contracture |
| 06/10/2008 | US7384917 oligopeptides having renin suppression, diuretic and/or vasodilator activity in mammals; treating congestive heart failure |
| 06/10/2008 | US7384915 Administering a chimeric fusion protein of insulin chain B, and glutamate decarboxylase (GAD) 65 peptides |
| 06/10/2008 | US7384913 Inducing oocyte activation by administering sperm perinuclear theca protein 34; interacts with tyrosine kinase; enhancing fertility; treating or diagnosing diminished fertility and abnormal spermiogenesis, providing contraception; identifying contraceptive and fertility-enhancing agents |
| 06/10/2008 | US7384912 Administering parathyroid hormone-related protein intermittently at a dosage of at least 500 mu g/day for at least one month,to increase bone mass densityat a rate of at least 1% per month; treating osteoporosis |
| 06/10/2008 | US7384911 Also for preventing and treating bacterial and fungal diseases in mammals; agricultural applications; |
| 06/10/2008 | US7384788 Regulator/promoter for tunable gene expression and metabolite sensing |
| 06/10/2008 | US7384784 Pax-encoding vector and use thereof |
| 06/10/2008 | US7384776 Expression vectors for increasing protein yield from a cell culture and methods of use thereof |
| 06/10/2008 | US7384775 Comprises nucleotide sequences coding surface localized streptococcal polypeptides for design of vaccines for prevention of non-systemic diseases such as otitis media; genetic vaccines |
| 06/10/2008 | US7384774 entirely vector-based intracellular system; introducing into a 293T cell expression vectors capable of expressing genomic or antigenomic vRNA segments, and a nucleoprotein, and an RNA-dependent polymerase |
| 06/10/2008 | US7384772 Binding, depolymerization; using enzyme catalyst ; isolated polynucleotides |
| 06/10/2008 | US7384768 Nucleic acids and polypeptides specific for pathogenic strains of the Neisseria genus |
| 06/10/2008 | US7384767 Nucleic acid encoding an interleukin-9 receptor variant |
| 06/10/2008 | US7384761 Methods of identifying an agent capable of interfering with Rad9 dephosphorylation |
| 06/10/2008 | US7384758 Bioluminescent protease assay with modified aminoluciferin or derivatives thereof |
| 06/10/2008 | US7384756 Methods for treating muscle diseases and disorders |
| 06/10/2008 | US7384752 Comprises membrane protein associated with neurons for treating brain disorders; antidepressant |
| 06/10/2008 | US7384750 Nucleic acid sequences having characteristics of enhanced expression in human neuroblastoma with favorable prognosis based on comparison between human neuroblastoma with favorable prognosis and human neuroblastoma with unfavorable prognosis |
| 06/10/2008 | US7384747 Screening nucleic acid comprising sequence that encodes reverse transciptase domain of DNA polymerase for adefovir-resistant mutations; use in vaccine development |
| 06/10/2008 | US7384740 Polynucleotide and protein involved in synaptogenesis variants thereof and their therapeutic and diagnostic uses |
| 06/10/2008 | US7384739 Derived from Thermococcus; thermostability; sequencing; kits |
| 06/10/2008 | US7384644 Modified Vaccinia Ankara virus variant |
| 06/10/2008 | US7384643 genetically engineered to be incapable of expressing a native A41L protein; binds to chemokines in the CXC group. |
| 06/10/2008 | US7384638 includes polypeptides that contain at least one antigenic portion of a Chlamydia antigen and DNA sequences encoding such polypeptides |
| 06/10/2008 | US7384636 Which induce an antibody specific to cell surface protein antigen from Streptococcus; use in vaccine production and preventing dental caries |
| 06/10/2008 | US7384635 Protein variants of naturally occurring allergens |
| 06/10/2008 | US7384634 Polypeptide, Connective Tissue Growth Factor (CTGF), polynucleotides encoding CTGF and polynucleotides regulating CTGF expression. The invention also provides agents that modulate CTGF and therapeutic methods for using the agents |
| 06/10/2008 | US7384627 Antitumor agents with the use of HSV |
| 06/10/2008 | CA2423481C Isolated peptides which bind to hla-c molecules and uses thereof |
| 06/10/2008 | CA2369869C Process for producing subunit peptide originating in polymer protein |
| 06/10/2008 | CA2365262C Surrogate cell-based system and method for assaying the activity of hepatitis c virus ns3 protease |
| 06/10/2008 | CA2358040C Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 06/10/2008 | CA2355897C Selecting animals for parentally imprinted traits |
| 06/10/2008 | CA2327743C Organic articles |
| 06/10/2008 | CA2284107C Activation of peptides |
| 06/10/2008 | CA2250075C Methods for diagnosing and treating alzheimer's disease |
| 06/10/2008 | CA2229028C Colon cell and colon cancer cell associated nucleic acid molecules, protein and peptides |
| 06/10/2008 | CA2191750C Virosome-mediated intracellular delivery of therapeutic agents |
| 06/10/2008 | CA2153756C Transport protein which effects the transport of cationic xenobiotics and/or pharmaceuticals, dna sequences encoding it and their use |
| 06/10/2008 | CA2113562C Poultry mycoplasma antigens, gene thereof and recombinant vectors containing the gene as well as vaccines utilizing the same |
| 06/10/2008 | CA2102417C Determination of glycated hemoglobin by fluorescence quenching |
| 06/06/2008 | WO2008127457A2 Nucleic acids encoding recombinant protein a |
| 06/05/2008 | WO2008067145A2 Self-assembling peptide amphiphiles |
| 06/05/2008 | WO2008066931A2 Bacillus licheniformis chromosome |
| 06/05/2008 | WO2008066752A2 Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir |
| 06/05/2008 | WO2008066749A2 Multi-epitope peptide-loaded dendritic cell immunotherapy for cancer |
| 06/05/2008 | WO2008066498A1 Cancer-related protein kinases |
| 06/05/2008 | WO2008066494A1 THERAPEUTIC USES OF β-ANTAGONISTS |
| 06/05/2008 | WO2008066463A1 Detection conjugate |
| 06/05/2008 | WO2008066444A1 Tslp vaccine for the treatment of th2 mediated inflammatory conditions |
| 06/05/2008 | WO2008066443A1 Il-33 vaccine for the treatment of inflammatory conditions with a strong th2 component |
| 06/05/2008 | WO2008066350A1 A novel ditpase and genes encoding it |
| 06/05/2008 | WO2008066032A1 Lymphangiogenesis inhibitory factor |
| 06/05/2008 | WO2008065673A1 A method for producing n-terminal methioine free polypeptides in microbial host cells |
| 06/05/2008 | WO2008065430A2 Promoter construct |
| 06/05/2008 | WO2008065415A2 Protein precipitation using a tag |
| 06/05/2008 | WO2008065372A2 Modified erythropoietin polypeptides and uses thereof for treatment |
| 06/05/2008 | WO2008065304A1 New drug for inhibiting, preventing or treatment of rheumatoid arthritis |
| 06/05/2008 | WO2008065053A1 Multi-modal cancer therapy using viral hitch-hiking |
| 06/05/2008 | WO2008064910A2 Metastasis-specific peptides and their diagnostic and therapeutic applications |
| 06/05/2008 | WO2008064686A1 Methods of separating nucleic acids and protein |
| 06/05/2008 | WO2008064570A1 The use of granulin-epithelin precursor (gep) antibodies for detection and suppression of hepatocellular carcinoma (hcc) |
| 06/05/2008 | WO2008064540A1 Compositions comprising adeno-associated virus-mediated anti-angiogenic factor-hgfk1 and uses thereof |
| 06/05/2008 | WO2008064488A1 Influenza vaccine formulation |
| 06/05/2008 | WO2008048407A3 Expression of streptomyces subtilisin inhibitor (ssi) proteins in bacillus and streptomyces sp. |
| 06/05/2008 | WO2008039818A3 Modified t cell receptors and related materials and methods |
| 06/05/2008 | WO2008035230A3 Liquid compositions comprising substantially purified igf at or below ph 5.0 |
| 06/05/2008 | WO2008031092A3 Immunostimulatory composition comprising lipoprotein in microalgae extract |
| 06/05/2008 | WO2008013454B1 Immunogenic compounds and protein mimics |
| 06/05/2008 | WO2007147395A3 Pathogen-inducible synthetic promoter |
| 06/05/2008 | WO2007124461A3 Glp-1 compounds |
| 06/05/2008 | WO2007117657A3 Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency |
| 06/05/2008 | WO2007108568A8 Hn epitope recognized by avian immune system and antigenic variant newcastle disease viruses carrying changes in the epitope |
| 06/05/2008 | WO2007066188A3 Marked bovine viral diarrhea virus vaccines |
| 06/05/2008 | WO2007021807A8 Mcp1 fusions |
| 06/05/2008 | WO2006078892A3 Use of a novel prostate specific membrane antigen for cancer diagnosis and therapy |
| 06/05/2008 | US20080134370 Novel Altered Gene from Rice Anthranilic Acid Synthase Gene Oasa2 and Use Thereof |
| 06/05/2008 | US20080134367 Nucleic acids encoding monomers of a type II serine proteinase inhibitor |
| 06/05/2008 | US20080134362 Nucleotide sequences mediating male fertility and method of using same |
| 06/05/2008 | US20080134359 Geminivirus Resistant Transgenic Plants |
| 06/05/2008 | US20080134358 Coleopteran-resistant transgenic plants and methods of their production |
| 06/05/2008 | US20080132687 Using erythropoietin as modulator of frataxin induction; treating neurodegenerative and cell proliferative disorders |
| 06/05/2008 | US20080132682 Method for manufacturing gelatin with reduced endotoxin content and low endotoxin gelatin |
| 06/05/2008 | US20080132681 Human Interferon Molecules and Their Uses |
| 06/05/2008 | US20080132680 Cytokine receptor fusion protein for use in identifying modulators for prevention a nd treatment of autoimmune and cell proliferative disorders |
| 06/05/2008 | US20080132484 Screening for a modulator of Polio Like Kinase, designing and identifying small molecule inhibitors using a homology model for PLK |
| 06/05/2008 | US20080132460 Screening for a compound which inhibits p62/ubiquitin binding; detecting the formation of inclusion bodies in neurodegenerative diseases; screening for therapeutic agents that disperse the inclusions |
| 06/05/2008 | US20080132454 bioavailable ACE-inhibiting peptides that are absorbed intact; protein hydrolysate; hydrolyzing the casein fraction using a protease, subtilisin; foods, beverages |
| 06/05/2008 | US20080132450 Pharmaceutical composition for suppression of apoptosis and method for delivering the same |
| 06/05/2008 | US20080132448 Conserved neisserial antigens |
| 06/05/2008 | US20080132446 Uses of neuronal pannexins for therapy and diagnosis in mammals |